-

What is a CBC Test?
What is a CBC Test? Learn about what a CBC test is and how the test can be used to help diagnose and monitor the progress of different types of cancer.
-

CLL Lab Tests Revealed: Navigating Care with Confidence
In this discussion, Dr. Adam Kittai and CLL patient advocate Michele Nadeem-Baker explain how common tests—like CBC, IGHV, and MRD—help guide diagnosis, prognosis, and when it’s time to start treatment.
-

Follicular Lymphoma Lab Tests Explained with Dr. Celeste Bello
In this discussion, explore how blood tests, biopsies, and scans guide follicular lymphoma care—from diagnosis and observation to active treatment. Dr. Celeste Bello breaks down what lab markers really mean and when changes signal it’s time to act.
-

DLBCL Tests Explained: How Blood, Biopsy, and Imaging Tests Impact Treatment Decisions
In this discussion, Dr. Robyn Stacy-Humphries, a three-time DLBCL survivor, moderates a conversation with lymphoma expert Dr. Tycel Phillips of City of Hope. Together, they unpack what blood tests can (and can’t) tell you, how biopsies and imaging are used, and what markers like LDH, neutrophils, and immunoglobulins mean during and after chemotherapy, CAR T-cell…
-

AML Labs Explained: What Blood and Bone Marrow Tests Reveal After Diagnosis
After an AML diagnosis, treatment often starts right away. Dr. Alice Mims explains what blood and bone marrow tests reveal about your condition and how they guide treatment.
-

Blood Work Basics: Making Sense of Your Test Results
Blood Work Basics: Making Sense of Your Test Results What do your blood test results really mean — and how do they help doctors detect or monitor cancer? Learn about the most common diagnostic tests, including the CBC and the CMP.
-

Understanding Cancer Blood Tests
Join hematopathologist Dr. Kamran Mirza and cancer advocate Stephanie Chuang to break down the most common diagnostic tests, including the CBC.
-

The Latest in Myelofibrosis Treatments
The Latest in Myelofibrosis Treatments: What Clinical Trials are Available to Me? Myelofibrosis experts John Mascarenhas, MD, from Mount Sinai and Tania Jain, MBBS, from Johns Hopkins explain cutting-edge therapies. Clinical trial nurse Ashley Giacobbi and myelofibrosis patient advocate Mary Linde share powerful insights to help you navigate all aspects of clinical trials.

